Botacini 1993.
Study characteristics | ||
Methods | Parallel Randomized Controlled Trial, Category B, Jadad 1 | |
Participants | Two hundred and fifty four women with HPV‐infection whose diagnostic was done by colposcopy, Pap smear, and direct biopsy by colposcopy allocated into five groups: 1) control n=16 2) Podophylin 4%, n=5 3) Podophylin 2%, n=40 4) 5‐Fluorouracil 5%, n=74 5) Meta‐cresol‐sulfonic acid, n=9 |
|
Interventions | Patients were randomised to five groups. 1) control (placebo) 2) Podophylin 4%, vaginal gel 5g in 15 applications in alternate days 3) Podophylin 2%, vaginal gel 5g in 15 applications in alternate days 4) 5‐fluorouracil 5%, 2 vaginal applications weekly for 8 weeks 5) Meta‐cresol‐sulfonic acid, in alternate days for 30 days |
|
Outcomes | 1) Cure ‐ defined as negative of colposcopy, Pap smear, and direct biopsy by colposcopy. 2) Partial response/ improvement ‐ defined as presence only of positive cytology for HPV infection 3) No response / resistance to the treatment ‐ defined as not alteration of the warts, CIN development or aggravation of lesions to the end of the study |
|
Notes | The follow‐up was done by 12 weeks 110 patients were excluded in the course of treatment because they did not follow the protocol requirement |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Quote: "In accordance with the effected treatment patients had been divided randomly in five groups..." Comment: Probably not done because there was no indication of the method used to distribute the patients, and because of the great difference of the "n" in each group |
Allocation concealment (selection bias) | Unclear risk | Quote:...patients had been divided randomly in five groups..." Comment: Probably not done. |
Blinding (performance bias and detection bias) All outcomes | Unclear risk | Not described Comment: Probably not done. |